Jacques Theurillat is a Swiss businessperson who founded EOS SpA and who has been the head of 7 different companies. Presently, he holds the position of Chairman for Vifor Pharma AG, Chairman at Vifor Pharma Management AG (a subsidiary of Vifor Pharma AG) and Partner at Sofinnova Partners SAS.
He is also on the board of Mundipharma, Inc., Napp Pharmaceutical Holdings Ltd., ADC Therapeutics SA and CNH Industrial NV and Partner at Sofinnova Crossover Fund.
In the past he was Chairman & Chief Executive Officer at Albea Pharmaceuticals AG, Chairman & Chief Executive Officer for AlbeaPharma AG, Managing Director at Istituto Farmacologico Serono, Deputy Chairman for Esaote SpA, Chief Executive Officer at Campus Holding SA, Managing Partner at Campus Holding SA and CFO & Deputy Chief Executive Officer at Serono SA.
Mr. Theurillat received a graduate degree from the University of Geneva, a graduate degree from Madrid University and an MBA from Centro de Estudios Financieros.